glp-1 kidney disease news treatments improve function in CKD patients Role of GLP1 RA in
Description
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 17 trials
This represents a sustained financial commitment, potentially long-term
Insurance typically covers GLP-1 medications prescribed for eligible conditions such as type 2 diabetes, obstructive sleep apnea, cardiac disease, vascular disease, kidney disease and stroke risk
This makes them a potential new strategy for preventing and treating AD, though their mechanisms of action and specific molecular pathways remain unclear
Oxyntomodulin has already shown to reduce food intake and bodyweight in rodents and humans ( In addition to GLP-1R/GCGR dual agonists, a chimeric peptide as dual GLP-1/GIP receptor agonists has been developed, showing enhanced therapeutic potential for obesity and related comorbidities
As discussed in the episode, GLP-1 medications are not a cure for endometriosis and should be considered one potential tool within a broader strategy
